Developing a Regulatory Strategy for Monoclonal Antibodies

Medical research is rapidly moving forward in the development of new diagnostics and therapeutics for life-threatening diseases. Among the most novel approaches to diseases such as cancer, septic shock, and multiple sclerosis, are the cell-targeting agents, monoclonal antibodies (MABs). Although man...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Drug information journal 1996, Vol.30 (1), p.257-267
Hauptverfasser:	Gore, Mugdha R., Hansen, Suzanne K., Miller, Loren L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Immunomodulators Medical sciences Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!